NDC Package 68727-745-05 Vyxeos

(daunorubicin And Cytarabine) Liposome Injection, Powder, Lyophilized, For Suspension - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68727-745-05
Package Description:
100 mL in 1 CARTON
Product Code:
Proprietary Name:
Vyxeos
Non-Proprietary Name:
(daunorubicin And Cytarabine) Liposome
Substance Name:
Cytarabine; Daunorubicin
Usage Information:
This medication is a combination product of daunorubicin and cytarabine liposome and is used to treat leukemia. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
11-Digit NDC Billing Format:
68727074505
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1942743 - cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection
  • RxCUI: 1942743 - cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection
  • RxCUI: 1942743 - ara-C liposome 100 MG / Daunorubicin Liposomal 44 MG Injection
  • RxCUI: 1942743 - cytarabine 100 MG / daunorubicin 44 MG Liposome Injection
  • RxCUI: 1942748 - Vyxeos 44 MG / 100 MG Liposome Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Jazz Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Suspension - A liquid preparation, intended for parenteral use that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Sample Package:
    No
    FDA Application Number:
    NDA209401
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-03-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 68727-745-05 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    68727074505J9153Inj daunorubicin, cytarabine1 MG/2.27 MG1544220

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    68727-745-0120 mL in 1 VIAL
    68727-745-0240 mL in 1 CARTON

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68727-745-05?

    The NDC Packaged Code 68727-745-05 is assigned to a package of 100 ml in 1 carton of Vyxeos, a human prescription drug labeled by Jazz Pharmaceuticals, Inc.. The product's dosage form is injection, powder, lyophilized, for suspension and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 68727-745 included in the NDC Directory?

    Yes, Vyxeos with product code 68727-745 is active and included in the NDC Directory. The product was first marketed by Jazz Pharmaceuticals, Inc. on August 03, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 68727-745-05?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 68727-745-05?

    The 11-digit format is 68727074505. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268727-745-055-4-268727-0745-05